Austco Healthcare Forecasts 52% Net Profit Surge with Major US Hospital Rollout
Austco Healthcare expects FY26 revenue between A$90 million and A$95 million, driven by strong sales and a significant US rollout. Net profit after tax is forecast to jump over 50%, supported by operational growth and a one-off benefit.
- FY26 revenue forecast A$90m–95m, up 11%–17%
- Net profit after tax expected to rise 52%–58%
- Pulse Mobile rollout across 180 US hospitals
- EBITDA margin slightly down to ~15.5% amid investments
- New contracts secured in Australia, New Zealand, Canada
Robust Profit Growth Despite Margin Pressure
Austco Healthcare Limited (ASX:AHC) is projecting a substantial jump in net profit after tax for FY26, with forecasts between A$9.0 million and A$9.4 million; an increase of 52% to 58% on FY25’s A$5.9 million. This surge is partly buoyed by a one-off A$1 million benefit from a reduction in contingent consideration related to its G&S acquisition. Revenue is expected to rise 11% to 17%, landing between A$90 million and A$95 million, reflecting steady demand across its global healthcare communication and workflow solutions.
While EBITDA is forecast to grow 7% to 12% to between A$14.0 million and A$14.6 million, the margin is expected to dip slightly to around 15.5%, down from 16% in FY25. Austco attributes this margin pressure to continued investments in personnel and capability, underscoring a strategic focus on long-term growth rather than short-term margin maximisation.
Major US Rollout and International Contract Wins
The standout operational highlight is the contracted rollout of Austco’s Pulse Mobile clinical communication platform across approximately 180 hospitals of its largest US customer during the 2026 calendar year. This rollout extends an existing relationship and signals strong market acceptance of Pulse Mobile’s role in enhancing clinical staff communication and workflow efficiency.
Alongside the US expansion, Austco has secured several significant contracts in other regions. In New Zealand, G&S Technologies won a NZ$1.1 million residential portfolio contract with a leading aged care provider. In Australia, Austco secured the Warrnambool Hospital Expansion project valued at around A$1.1 million, continuing its track record in public hospital infrastructure. Canada’s North York General Hospital, a University of Toronto teaching hospital, awarded a purchase order worth approximately A$0.9 million for a long-term care project.
Navigating Supply Chain and Geopolitical Challenges
Austco’s growth comes despite tougher trading conditions in H2 FY26, including longer freight transit times and higher logistics costs driven by geopolitical tensions in the Middle East and disruptions to global shipping lanes. Supply constraints on electronic components, particularly advanced semiconductors in high demand from the AI sector, have also posed challenges. The company credits disciplined execution, proactive supply chain management, and strong customer relationships for maintaining momentum and delivery capability.
Some slower construction programs have deferred installations and revenue recognition, but Austco emphasises that these are timing shifts rather than lost opportunities. The company enters FY27 with a healthy sales pipeline and sustained momentum across all regions, positioning it well for continued growth.
Bottom Line?
Austco’s FY26 outlook balances strong profit growth with margin pressure and supply chain headwinds, setting the stage for a pivotal US rollout and a cautiously optimistic FY27.
Questions in the middle?
- How will Austco manage margin pressures amid ongoing investments and supply chain risks?
- What impact will the US Pulse Mobile rollout have on revenue recognition and cash flow in FY27?
- Can Austco convert its healthy sales pipeline into sustained growth beyond FY27?
